Ketamine Completed Phase 1 Trials for Schizophrenic Disorders Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT01165294The Effect of Ketamine on Attentiveness
NCT01749098A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers